# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-25-000247
Filing Date
2025-01-03
Accepted
2025-01-03 16:15:23
Documents
29
Period of Report
2025-01-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 39167
2 |  | ex99-1.htm | EX-99.1 | 12034
3 |  | ex99-1_001.jpg | GRAPHIC | 388283
4 |  | ex99-1_002.jpg | GRAPHIC | 380833
5 |  | ex99-1_003.jpg | GRAPHIC | 476549
6 |  | ex99-1_004.jpg | GRAPHIC | 343746
7 |  | ex99-1_005.jpg | GRAPHIC | 361747
8 |  | ex99-1_006.jpg | GRAPHIC | 378351
9 |  | ex99-1_007.jpg | GRAPHIC | 300736
10 |  | ex99-1_008.jpg | GRAPHIC | 165739
11 |  | ex99-1_009.jpg | GRAPHIC | 263256
12 |  | ex99-1_010.jpg | GRAPHIC | 392110
13 |  | ex99-1_011.jpg | GRAPHIC | 423917
14 |  | ex99-1_012.jpg | GRAPHIC | 273203
15 |  | ex99-1_013.jpg | GRAPHIC | 288337
16 |  | ex99-1_014.jpg | GRAPHIC | 370551
17 |  | ex99-1_015.jpg | GRAPHIC | 239014
| Complete submission text file | 0001493152-25-000247.txt |  | 7181045

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
18 | XBRL SCHEMA FILE | envb-20250103.xsd | EX-101.SCH | 3012
19 | XBRL LABEL FILE | envb-20250103_lab.xml | EX-101.LAB | 34240
20 | XBRL PRESENTATION FILE | envb-20250103_pre.xml | EX-101.PRE | 24163
31 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3827

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 25506395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)